Inventors:
Mariah Baughn - Los Angeles CA, US
Catherine Tribouley - San Francisco CA, US
Danniel Nguyen - San Jose CA, US
Michael Thornton - Oakland CA, US
Monique Yao - Mountain View CA, US
Deborah Kallick - Galveston TX, US
Ameena Gandhi - San Francisco CA, US
Narinder Chawla - Union City CA, US
Chandra Arvizu - San Diego CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Pei Jin - Palo Alto CA, US
Y Tang - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Roopa Reddy - Sunnyvale CA, US
Neil Burford - Durham CT, US
Dyung Lu - San Jose CA, US
Richard Graul - San Francisco CA, US
Farrah Khan - Des Plaines IL, US
Roderick Walsh - Kent, GB
Craig Ison - San Jose CA, US
Thomas Richardson - Redwood City CA, US
Jennifer Griffin - Fremont CA, US
Bridget Warren - San Marcos CA, US
Junming Yang - San Jose CA, US
Ernestine Lee - Castro Valley CA, US
Lee Harland - Canterbury, GB
International Classification:
C12Q001/68
C07H021/04
C07K014/705
C07K016/28
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 530/388220, 536/023500
Abstract:
The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.